Literature DB >> 2886808

Severe parkinsonism in two AIDS patients taking prochlorperazine.

H Edelstein, R T Knight.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2886808     DOI： 10.1016/s0140-6736(87)90937-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Brain-derived neurotrophic factor expression in the substantia nigra does not change after lesions of dopaminergic neurons.

Authors:  Italo Mocchetti; Alessia Bachis; Rachel L Nosheny; Gianluigi Tanda
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

Review 2.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

3.  Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.

Authors:  Andrew J Levine; Janet S Sinsheimer; Robert Bilder; Paul Shapshak; Elyse J Singer
Journal:  J Clin Exp Neuropsychol       Date:  2011-11-14       Impact factor: 2.475

Review 4.  When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?

Authors:  Italo Mocchetti; Lee A Campbell; G Jean Harry; Valeriya Avdoshina
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-15       Impact factor: 4.147

5.  Nigral degeneration in acquired immune deficiency syndrome (AIDS).

Authors:  M G Reyes; F Faraldi; C S Senseng; C Flowers; R Fariello
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 6.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

7.  Neuroleptic malignant syndrome in an AIDS patient: clinical and pathological findings.

Authors:  A S Gabellini; A Pezzoli; P De Massis; G Casadei; A Grillo; T Sacquegna
Journal:  Ital J Neurol Sci       Date:  1994-09

8.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

Review 9.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 10.  Use of psychotropic drugs in patients with HIV infection.

Authors:  J L Ayuso
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.